Personalized cancer vaccine to prevent solid tumor recurrence
Part of Cancer clinical trials.
This trial tests a personalized cancer vaccine, made specifically for your tumor, combined with a medicine called toripalimab (which helps your immune system fight cancer). It is designed for people who have had surgery for a solid tumor and are getting additional therapy to try to prevent the cancer from coming back.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You should be in generally good health (able to do light activities).
- You need to have a solid tumor (like lung, colon, or breast cancer) and be receiving or planning to receive extra treatment after surgery to help prevent the cancer from returning.
- You cannot have had systemic anti-cancer treatment (like chemo or immunotherapy) for this cancer before your current treatment plan.
- You must not have had other cancers within the past 5 years, except for certain cured early-stage cancers.
- You must not have serious lung conditions like interstitial lung disease or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized vaccine designed to train your immune system to fight any remaining cancer cells after surgery or during standard therapy. It is for people with solid tumors who are stable and have no signs of disease getting worse.
This trial tests a personalized cancer vaccine, given alone or with an immunotherapy drug called toripalimab, in people with non-small cell lung cancer (NSCLC) who have had surgery and are getting adjuvant therapy (treatment to prevent the cancer from coming back). The goal is to see if the vaccine is safe and may help the immune system fight any remaining cancer cells.
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
This trial tests a personalized vaccine made from unique markers on your tumor cells (called neoantigens). The goal is to help your immune system fight the cancer more effectively. It is for people with advanced solid tumors who have not had gene therapy and are otherwise relatively healthy.
This trial tests a new vaccine made from your own tumor cells to see if it can help your immune system fight the cancer. It is for people with advanced solid tumors that have not responded to other treatments.
This trial tests a new investigational drug called ABO2011, which is injected directly into tumors. It is for people with advanced solid tumors that have not responded to previous treatments. The goal is to see if the drug is safe and can help shrink or slow tumor growth.
Hear when a new Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.